SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ABT - Abbott Labs
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
328 12 0 ABT
Emcee:  Masood Ahmed Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
278 KidsGrowth.com, LLC and the Ross Products Division of Abbott Laboratories Join Skywatcher-6/14/2000
277 I knew about the ED drugs, just not about rumors surrounding the euro connectioSkywatcher-6/12/2000
276 Chris, Thanks for the response. The Abbott/Vivus European partnership rumor hasFrostman-6/12/2000
275 Sorry I don't know anything specific about Vivus and the partnering effort Skywatcher-6/12/2000
274 Chris, I am a long-term Vivus shareholder. What do you or any Abbott oriented fFrostman-6/11/2000
273 Abbott Announces 25 Million Share Buyback, Declares Quarterly Dividend ABBOTT Skywatcher-6/9/2000
272 Abbott Elects Dr. Jeffrey Leiden Chief Scientific Officer ABBOTT PARK, Ill., JuSkywatcher-6/8/2000
271 American Biogenetic Sciences, Inc. Announces a Program to Accelerate DevelopmenSkywatcher-6/5/2000
270 Abbott Laboratories Submits New Drug Application in the U.S. For InvestigationaSkywatcher-6/1/2000
269 Bayer says to make rival to Viagra FRANKFURT, May 31 (Reuters) - German drug maSkywatcher-5/31/2000
268 Abbott sues Boston hospital over cancer treatment BOSTON, May 31 (Reuters) - DrSkywatcher-5/31/2000
267 It's a conservative call. ABT was way ahead of itself the last time it was Victoria Walley-5/26/2000
266 Abbot Laboratories (ABT:NYSE - news - boards): NEW outperform at ABN Amro; 12- Skywatcher-5/26/2000
265 TAP launches research with IPF PharmaCeuticals LAKE FOREST, Ill., May 24 (ReuteSkywatcher-5/24/2000
264 New CDC Recommendations for Management of Community-Acquired Pneumonia Include Skywatcher-5/24/2000
263 The chart looks great...and plenty of strength on price. volume is down but so Skywatcher-5/24/2000
262 Nice to see so much strength from this stock in such an otherwise crummy marketVictoria Walley-5/23/2000
261 From an article last week: Another up-and-comer worth a look is SangStat MedicaSkywatcher-5/23/2000
260 SOURCE: Abbott Laboratories TAP Pharmaceutical Products Inc. Partners With AmerSkywatcher-5/23/2000
259 Was just reading through the consent decree from last year. Hard to believe theRWReeves-5/20/2000
258 NEW YORK (CBS.MW) --Abbott Laboratories and SangStat said they received approvaSkywatcher-5/18/2000
257 Abbott Labs is a great company and is a teriffic buy under $35 per share, IMO. Hamilton Rogers-3/24/2000
256 Maybe this news helped the stock today: Dow Jones Newswires -- February 3, 2000John Chatterton-2/4/2000
255 Does anyone know the FDA approval status of ABT's anti-Erectile DysfunctionJohn Chatterton-2/4/2000
254 Charles: What is you outlook on ABT short term (3 mths) and 12 mths. Thanks. Doug-12/10/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News